Skip to main
UNH
UNH logo

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 42 analyst ratings
Buy
Strong Buy 38%
Buy 48%
Hold 10%
Sell 5%
Strong Sell 0%

Bulls say

The provided excerpts indicate a positive outlook for UnitedHealth Group, driven by a projected growth in Medicare Advantage (MA) enrollment, expected to increase by approximately 800,000 members year-over-year, translating to a 10% rise in overall enrollment. Additionally, the company's focus on HMO growth, which is seen as more manageable in terms of costs compared to PPO, further supports its robust growth strategy in the evolving healthcare market. Furthermore, management anticipates an acceleration in earnings per share (EPS) growth towards the range of 13-16% by 2026, alongside an improved margin profile for its OptumInsight segment, which is expected to enhance overall financial performance.

Bears say

UnitedHealth Group has experienced a sequential decline in Optum Health consumers, dropping to 100 million from 104 million in the third quarter, which raises concerns about membership retention and growth potential. The fourth-quarter earnings per share of $6.81, although above street estimates, highlighted a managed care ratio (MLR) miss at 87.6%, driven primarily by lower revenue linked to Medicare Advantage group refunds and increased seasonal costs from flu and RSV. Additionally, the company faces significant investment risks, including regulatory pressures related to Medicare and Medicaid, ineffective pricing strategies, and rising utilization of medical services, all of which could adversely impact financial performance and outlook.

UnitedHealth Group (UNH) has been analyzed by 42 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 48% recommend Buy, 10% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 42 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Jul 1, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $392.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $392.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.